Computational design of ligand-binding proteins with high affinity and selectivity
暂无分享,去创建一个
David Baker | Barry L. Stoddard | Sagar D. Khare | Lindsey Doyle | Jiayi Dou | Christine E. Tinberg | Jorgen W. Nelson | Alberto Schena | Wojciech Jankowski | Charalampos G. Kalodimos | Kai Johnsson | D. Baker | B. Stoddard | L. Doyle | S. Khare | C. Tinberg | C. Kalodimos | Jorgen W Nelson | K. Johnsson | Jiayi Dou | W. Jankowski | Alberto Schena | D. Baker | D. Baker
[1] B. Shilton,et al. Structural studies of an engineered zinc biosensor reveal an unanticipated mode of zinc binding. , 2005, Journal of molecular biology.
[2] Eric A. Althoff,et al. De Novo Computational Design of Retro-Aldol Enzymes , 2008, Science.
[3] David Baker,et al. Structural analyses of covalent enzyme-substrate analog complexes reveal strengths and limitations of de novo enzyme design. , 2011, Journal of molecular biology.
[4] Birte Höcker,et al. Computational design of ligand binding is not a solved problem , 2009, Proceedings of the National Academy of Sciences.
[5] D. Baker,et al. Restricted sidechain plasticity in the structures of native proteins and complexes , 2011, Protein science : a publication of the Protein Society.
[6] Jasmine L. Gallaher,et al. Computational Design of an Enzyme Catalyst for a Stereoselective Bimolecular Diels-Alder Reaction , 2010, Science.
[7] Eric A. Althoff,et al. Kemp elimination catalysts by computational enzyme design , 2008, Nature.
[8] Colin W. Taylor,et al. Analysis of protein-ligand interactions by fluorescence polarization , 2011, Nature Protocols.
[9] John McCafferty,et al. Beyond natural antibodies: the power of in vitro display technologies , 2011, Nature Biotechnology.
[10] D. Baker,et al. Role of conformational sampling in computing mutation‐induced changes in protein structure and stability , 2011, Proteins.
[11] D. Baker,et al. Native protein sequences are close to optimal for their structures. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[13] Jens Meiler,et al. New algorithms and an in silico benchmark for computational enzyme design , 2006, Protein science : a publication of the Protein Society.
[14] D. Baker,et al. High Resolution Mapping of Protein Sequence–Function Relationships , 2010, Nature Methods.
[15] G. Brett,et al. Ligand-binding proteins: their potential for application in systems for controlled delivery and uptake of ligands. , 2000, Pharmacological reviews.
[16] A. Fersht,et al. Hydrogen bonding and biological specificity analysed by protein engineering , 1985, Nature.
[17] R. Nussinov,et al. The role of dynamic conformational ensembles in biomolecular recognition. , 2009, Nature chemical biology.
[18] David Baker,et al. Role of the Biomolecular Energy Gap in Protein Design, Structure, and Evolution , 2012, Cell.
[19] Sarel J Fleishman,et al. Emerging themes in the computational design of novel enzymes and protein–protein interfaces , 2013, FEBS letters.
[20] K Dane Wittrup,et al. Isolating and engineering human antibodies using yeast surface display , 2006, Nature Protocols.
[21] Adrien Treuille,et al. Predicting protein structures with a multiplayer online game , 2010, Nature.
[22] Douglas M. Fowler,et al. Enrich: software for analysis of protein function by enrichment and depletion of variants , 2011, Bioinform..
[23] David Baker,et al. An exciting but challenging road ahead for computational enzyme design , 2010, Protein science : a publication of the Protein Society.
[24] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[25] David Baker,et al. Bridging the gaps in design methodologies by evolutionary optimization of the stability and proficiency of designed Kemp eliminase KE59 , 2012, Proceedings of the National Academy of Sciences.
[26] A. Wand,et al. Conformational entropy in molecular recognition by proteins , 2007, Nature.
[27] Jens Meiler,et al. RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite , 2011, PloS one.
[28] T. Kosten,et al. Vaccines Against Drug Abuse , 2012, Clinical pharmacology and therapeutics.
[29] L. Benatuil,et al. An improved yeast transformation method for the generation of very large human antibody libraries. , 2010, Protein engineering, design & selection : PEDS.
[30] G. Georgiou,et al. Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS) , 2001, Nature Biotechnology.
[31] F. Arnold,et al. Optimizing non-natural protein function with directed evolution. , 2011, Current opinion in chemical biology.
[32] Timothy A. Whitehead,et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing , 2012, Nature Biotechnology.
[33] David Baker,et al. De Novo Enzyme Design Using Rosetta3 , 2011, PloS one.
[34] H. Wolfson,et al. Shape complementarity at protein–protein interfaces , 1994, Biopolymers.
[35] E. Haber,et al. High-affinity monoclonal antibodies to the cardiac glycoside, digoxin. , 1982, Journal of immunology.
[36] F. J. Poelwijk,et al. The spatial architecture of protein function and adaptation , 2012, Nature.